In this episode, Joe Moore of Psychedelics Today sits down with Paul Austin, founder of The Third Wave, to dive deep into the evolution of microdosing and its growing role in psychedelic culture. Paul shares how his journey with microdosing LSD led him to launch The Third Wave in 2015 to make psychedelics more accessible through education. The conv…

In this episode of Psychedelics Today, Joe Moore sits down with Louis Dorian, the visionary behind Psychedelist, a groundbreaking global platform designed to support the emerging psychedelic movement. Described as a “cyber city” for all things psychedelic, Psychedelist connects individuals with treatment providers, educators, facilitators, legal ex…

In this episode of Psychedelics Today, Joe Moore is joined by Neeka Levy and Zach Skiles of Heal Ukraine Trauma, a nonprofit bringing psychedelic-assisted therapy to veterans and civilians affected by war. They discuss the organization’s origins, the impact of intergenerational trauma in Ukraine, and the evolving role of psychedelic treatments in a…

In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-world settings, the role of metaphysical perspectives in research, and wh…

In this episode, Joe interviews Nico and Susan Simon: Co-founders of JourneyŌM, a concierge service looking to address the question many people are asking: How do you find the right facilitator? Through a dedicated vetting process, JourneyŌM is adding a layer of risk reduction and accountability to this strange new world, by traveling the country a…

In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris. After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DO…

In this episode, Joe interviews Jeremy Falk: certified instructor and training program developer for Kama Flight; and Dr. David Rabin, MD, Ph.D.: board-certified psychiatrist and neuroscientist, co-founder & chief Medical Officer at Apollo Neuroscience, and advisor to the non-profit, Kama Flight Foundation. Kama Flight is a wellness modality for pa…

In this episode, Joe interviews Ariel Clark: Anishinaabe attorney and co-founder of the Psychedelic Bar Association, a national association of lawyers involved in the highly-regulated ecosystem of psychedelic law. She talks about ethics: How do the different societal norms of each lineage we carry interact with each other? What is the cultural fram…

In this episode, Joe interviews Angie Roullier: longtime veteran of the cannabis industry and author of the book, Pot for the People: The Plant, the People, and the Shop Policies of Cannabis. Diagnosed with the neurological disorder, Charcot-Marie-Tooth (CMT), Roullier tells the story of how cannabis replaced all her medications, which led to a per…

In this episode, Kyle interviews Tommy Aceto: former Navy Seal and trauma medic, and now, ambassador for the Veteran Mental Health Leadership Coalition and advisor at Beond Ibogaine. He talks about how much the psychedelic space focuses on healing and mental health, but doesn’t talk enough about the overall wellness that can come from a consistent …

In this episode, Joe interviews Melanie Curtis: world record professional skydiver, keynote speaker, coach, co-host of the Trust the Journey podcast, and author of How to Fly: Life Lessons From a Professional Skydiver. Curtis shares her journey from taking her first transformative leap out of an airplane to becoming a leader in skydiving, public sp…

In this episode, Joe interviews Dan Ronken: licensed professional counselor and addiction counselor with a private practice in Boulder, CO, called Inclusion Recovery, and lead trainer and facilitator for the Integrative Psychiatry Institute (IPI). He tells his story of going from a sponsored BMX racer to three stints in rehab before the age of 14, …

In this episode, Joe interviews Shauheen Etminan, Ph.D.: co-founder of VCENNA, a drug discovery and development company, and Magi Ancestral Supplements, which sells nootropics inspired by ancient Eastern traditions. He discusses his journey into the world of plant extraction, how he first discovered compounds like Haoma and Harmaline, and why he de…

In this episode, Joe interviews Paul Grof: research psychiatrist, clinician, author, brother of Stanislav, professor of psychiatry at the University of Toronto, and director of the Ottawa Mood Disorders Center. He talks about his extensive career in psychiatry, and how trying to understand the cause of mood disorders led him to focusing on the very…

In this episode, Joe interviews Kat Murti: executive director of Students for Sensible Drug Policy (SSDP), the largest nationwide network of students fighting to replace the War on Drugs with policies rooted in evidence, compassion, and human rights. She talks about how she became interested in drug policy, which not surprisingly aligns with the ma…

In this episode, Joe interviews Howard Kornfeld, MD: renowned pain medicine expert, addiction specialist, early pioneer in psychedelic medicine, and currently the director of recovery medicine at Recovery Without Walls. As a leader in the utilization of buprenorphine, he talks about how it came about as a treatment for addiction and chronic pain, i…

In this episode, Joe interviews Veronica Lightning Horse Perez: therapist, speaker, author, activist, and co-chief proponent for the Natural Medicine Health Act of 2022 (Prop 122); and Sean McAllister: attorney specializing in the regulatory, health care, business, and religious freedom aspects of psychedelic medicines, and one of the drafters of P…

In this episode, Joe interviews two members of the Heroic Hearts Project: Founder and President, Jesse Gould; and Director of Development and Head of Family Relations, Allison Wilson. Gould gives a background of Heroic Hearts Project and discusses their current projects and future goals, and Wilson talks about her nonprofit, The Hope Project, and i…

In this episode, Victoria interviews Max Montrose: Founder of the Trichome Institute, a company offering online courses and certifications on cannabis. Montrose explores the scientific and sensory aspects of cannabis, diving into the role of the aromatic compound, indole, and how the fresher and more aromatic (usually pungent) the flower is, the hi…

In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry. Bouchard introduces his 3-axis framework for psychedelic integration, which looks at the personal, the transpersonal, and, with time, seeing how the lessons learned from no…

In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her personal journey with psychedelics and how they unlocked deep trauma, allowing her to develop a level of comfort with intimacy, love, and her sexuality…

In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges and controversies facing a ketamine industry that has moved much faster than anyone anticipated, and stresses the need to create industry-wide standar…

In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketamine-assisted therapy and psychedelic integration. He talks about what he feels is one of the largest factors in our mental health crisis: the individua…

In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found that people were having great success, but nobody could recommend where to go for treatment. So he worked to create what was needed: a combination of a…

In this episode, David interviews Floris Wolswijk: senior project manager at Delphi; co-founder of FLO coaching; and founder of Blossom, an online informational hub collecting psychedelic courses, trials, companies, and over 2000 categorized research articles. When Wolswijk began Blossom, he was barely able to fill a weekly newsletter, and now he’s…

In this episode, Joe interviews Jessica Tracy: head of sales & partnerships at Enthea, a company that works with employers, unions, and employee assistance programs to be able to offer ketamine-assisted therapy (and psilocybin where it’s legal) to employees. She talks about her path to psychedelics and how the shifts in her life led her to want to …

In this episode, Joe and Kyle finally meet up again for the first episode of Psychedelics Lately: the updated version of the much-missed Psychedelics Weekly, where they’ll meet each month to talk about the most interesting stories in psychedelics. The main story this month is the fate of Massachusetts’ Question 4: Regulated Access to Psychedelic Su…

In this episode, Joe interviews Dr. Peter Sjöstedt-Hughes: philosopher, lecturer at the University of Exeter, co-director of the Breaking Convention conference, and author who most recently co-edited Philosophy and Psychedelics: Frameworks for Exceptional Experience. He discusses how the work of William James and an early psilocybin experience led …

In this episode, Joe interviews 4 members of the Penn Psychedelics Collaborative: Co-Founder, Taylor Andrews Flatt, PMHNP; Associate Director, Victor Pablo Acero, Ph.D.; Professor in Fine Arts and Co-Director of the Weitzman School of Design, Jackie Tileston; and Executive Director and Director of the Penn Program for Mindfulness, Michael Baime, MD…

In this episode, Joe interviews two people on the frontlines of the campaign for Massachusetts' Question 4: The Natural Psychedelic Substances Act: Graham Moore and Community Engagement Director, Jamie Morey. They discuss the specifics of the initiative, listed on the ballot as the “Limited Legalization and Regulation of Certain Natural Psychedelic…

In this episode, Joe interviews Diana Quinn, ND: naturopathic doctor, healing justice practitioner, and director of clinical education at the Naropa Center for Psychedelic Studies, where she directs their Psilocybin Facilitator Training certificate program. She discusses her path from anthropology to naturopathy, and eventually to psychedelics and …

In this episode, Joe interviews Rick Doblin, Ph.D.: founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS), and former board member at Lykos Therapeutics, MAPS’ public benefit subsidiary. Doblin tells his side of the story: that the FDA’s concerns with double blinding not working had been fully addressed ahead of …

In this episode, Kyle interviews Gabriela Galindo: program coordinator of FLOWS (Foundations for Leaders Organizing for Water and Sustainability), an organization working towards social and environmental justice, ecosystem restoration, community building, and the preservation and protection of Indigenous medicines. She discusses her entry point to …

In this episode, Joe interviews Mareesa Stertz: lead of strategy/communications at the Global Psychedelic Society, co-founder of Lucid News, and filmmaker, currently finalizing her second feature film, “Confessions of a Psychonaut.” She discusses her path to wanting to create the film: how she always felt like something was wrong with her but didn’…

In this episode, Joe interviews Micah Stover: certified psychedelic somatic therapist and author of the upcoming book, Healing Psychedelics: Innovative Therapies for Trauma and Transformation; and Craig Heacock, MD: adolescent, adult, and addiction psychiatrist, and host of the Back from the Abyss podcast. Stover discusses the inspiration for the b…

In this episode, David interviews Glauber Assis, Ph.D.: research associate at the Interdisciplinary Group for Psychoactive Studies, director of the Psychedelic Parenthood community, Vital instructor, and leader of Jornadas de Kura, a plant medicine center in Brazil. He talks about growing up in Brazil in the shadows of colonialism, and how he felt …

In this episode, Joe interviews award-winning novelist and screenwriter, Norman Ohler. Following in the footsteps of "Blitzed: Drugs in the Third Reich," his newest book, "Tripped: Nazi Germany, the CIA, and the Dawn of the Psychedelic Age," tells the story of how the Nazi’s passion for methamphetamine turned into a curiosity about LSD, and how the…

In this episode, Kyle interviews Lana Pribic, M.Sc: host of the Modern Psychedelics podcast, certified professional life coach, and founder of Kanna Wellness. She talks about her early days of rave culture and MDMA, to exploring other substances, to where she is today: finding joy in the simple things in life, embracing recreational psychedelics, a…

In this episode, Joe interviews Ingmar Gorman, Ph.D.: clinical psychologist and co-founder and CEO of Fluence, a psychedelic education company. Gorman served as a co-principal investigator and study therapist on MAPS’ Phase II and III clinical trials for MDMA-assisted psychotherapy for PTSD, and works with drug sponsors: training, developing the co…

In this episode, Kyle interviews Beth Weinstein: spiritual business coach, host of the “Medicine For These Times” podcast, and founder of the Psychedelics, Sacred Medicines, Soul’s Purpose & Business summit. She talks about a pattern she noticed of people working with psychedelics and seeing progress on what they set out to heal, but with a short-l…

In this episode, David interviews Daniel Shankin: psychedelic integration coach, Vital instructor, and founder and director of Tam Integration. He talks about the underrated importance of integration circles, how he created Tam Integration out of a personal need for them, how simple it can be for people to create their own groups, and how open-ende…

In this episode, Joe interviews Joanna Kempner, Ph.D.: associate professor in the Department of Sociology at Rutgers University and author of the recently released, Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine. The book profiles the history and groundbreaking work of ClusterBusters, a nonprofit researching and spreading awarene…

In this episode, Kyle interviews Mustapha Khan: Emmy Award-winning director with over 100 film and television credits, who has worked with clients such as Coca-Cola and Honda, and celebrities ranging from Maya Angelou to Snoop Dogg. Khan is finalizing a film about Lenny and Elizabeth Gibson and their ongoing work at Dreamshadow – the people and com…

In this episode, Joe interviews Danielle Nova: founder of Psychedelic Recovery, founding team member of Decriminalize Nature Oakland, and Executive Director of the San Francisco Psychedelic Society. As a recovering addict, Nova discusses how working with psychedelics helped her find her way to recovery, and how she's spreading that knowledge to oth…

In this episode of Vital Psychedelic Conversations, David interviews Deanna Rogers: Registered Clinical Counselor and Vital instructor. She discusses how trauma grows in our bodies, and the importance of practitioners and facilitators becoming trauma-informed before working with clients. She stresses the need to create the right conditions for clie…

In this episode, Joe interviews Jean Lacy: Executive Director of the Illinois Psychedelic Society; and La Shawn K. Ford: 17-year member of the Illinois House of Representatives, representing the 8th District. Together, they are working on the CURE (Compassionate Use and Research of Entheogens) Act, which aims to decriminalize plant medicines and br…

In this episode of Vital Psychedelic Conversations, David interviews Rachelle Sampson, Ph.D.: researcher and founder of Blue Prism Coaching; and Bennet Zelner, Ph.D.: researcher, speaker, and creator of the Pollination Approach. They are both Vital instructors and Associate Professors at the Robert H. Smith School of Business, University of Marylan…

As the psychedelic renaissance continues to spread throughout the West, we learn more about these substances and experiences every day. But are we losing the important ancestral teachings and Indigenous knowledge that got us here? In this episode, Kyle interviews Alonso Del Río: author, musician, filmmaker, founder of the Center for Healing and Con…

In this episode of VItal Psychedelic Conversations, Vital instructor, Diego Pinzon hosts his first podcast, interviewing Vital graduate and clinically-trained psychologist, “The Kinki Buddhist”: Kate Amy. As Amy’s interest in psychedelics grew, she began to see a clear intersection between psychedelic states and the non-ordinary states she’d reache…

In this episode, Chris Koddermann interviews two members of the Center for the Neuroscience of Psychedelics at Mass General Hospital: founding director, author, and co-founder of three drug development companies, Dr. Jerry Rosenbaum; and psychiatrist and associate director and director of cognitive neuroscience, Sharmin Ghaznavi, MD, Ph.D. Rosenbau…